Drilldown: Medicines
Use the filters below to narrow your results.
generic:
brand:
classes: (Click arrow to add another value)
mechanism:
None (1) ·
1-acetyl-LSD; prodrug of LSD (1) ·
5-HT2A agonist (26) ·
5-HT2A agonist; D2 partial agonist (1) ·
5-HT2A agonist; long duration (1) ·
5-HT2A agonist; MAO inhibitor (1) ·
5-HT2A agonist; milder than other 2C-x (1) ·
5-HT2A agonist; minor psilocybin mushroom alkaloid (1) ·
5-HT2A agonist; primarily auditory effects (1) ·
5-HT2A agonist; sigma-1 agonist (1) ·
5-HT2A partial agonist (2) ·
Contains bufotenin and DMT (1) ·
Contains LSA (2) ·
Contains mescaline (2) ·
Contains psilocybin and psilocin (1) ·
DMT + MAOI (harmine/harmaline); 5-HT2A agonist (1) ·
Extremely potent 5-HT2A agonist; vasoconstrictor (1) ·
Extremely potent 5-HT2A agonist; very long duration (1) ·
LSD analogue; 5-HT2A agonist (4) ·
Lysergic acid 2,4-dimethylazetidide; 5-HT2A agonist (1) ·
Lysergic acid hydroxyethylamide; 5-HT2A agonist (1) ·
Monoamine releasing agent; 5-HT2A agonist (1) ·
Potent 5-HT2A agonist (5) ·
Potent 5-HT2A agonist; no oral activity (1) ·
Potent 5-HT2A agonist; sigma-1 agonist (1) ·
Potent 5-HT2A agonist; very long duration (1) ·
Prodrug of 4-HO-DET; 5-HT2A agonist (1) ·
Prodrug of 4-HO-DiPT; 5-HT2A agonist (1) ·
Prodrug of 4-HO-MET; 5-HT2A agonist (1) ·
Prodrug of 4-HO-MiPT; 5-HT2A agonist (1) ·
Prodrug of LSD; 5-HT2A agonist (4) ·
Prodrug of psilocin; 5-HT2A agonist (1) ·
Serotonin/dopamine/norepinephrine releasing agent; 5-HT2A agonist (1) ·
Very potent 5-HT2A agonist; long duration (1)
uses:
starting dose:
preparations:
routes:
onset:
None (69) ·
30–60 minutes (1) ·
45-75 min (oral) (1) ·
Peak plasma concentration in 2-4 hours after oral administration. Clinically perceptible wakefulness-promoting effects typically begin within 1-2 hours of dosing.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
duration:
None (69) ·
4-8 h (1) ·
8–12 hours (1) ·
Effective duration approximately 12-15 hours at the 200 mg dose, consistent with the elimination half-life. A single morning dose generally sustains wakefulness throughout the day without substantially disrupting nighttime sleep onset when taken early.'"`UNIQ--ref-0000006D-QINU`"' (1)
halflife:
bioavailability:
None (69) ·
70–90% (oral) (1) ·
Not well characterized (1) ·
Oral bioavailability is not precisely established in the label but absorption is rapid and essentially complete. Food delays peak plasma concentration by approximately one hour but does not reduce the extent of absorption.'"`UNIQ--ref-0000006F-QINU`"' (1)
pregnancy:
Showing below up to 97 results in range #1 to #97.